January 25, 2018 / 5:07 PM / Updated 10 minutes ago BRIEF-Adocia Announces Positive Topline Data From Study Of Biochaperone® Reuters Staff 1 Min Read 
Jan 25 (Reuters) - Adocia Sa: 
* ADOCIA ANNOUNCES POSITIVE TOPLINE DATA FROM A DOSE-PROPORTIONALITY STUDY OF BIOCHAPERONE® COMBO IN PEOPLE WITH TYPE 2 DIABETES 
* ADOCIA SA - STUDY CONFIRMED PREVIOUS RESULTS THAT BIOCHAPERONE COMBO ACTS SIGNIFICANTLY FASTER AND LASTS SIGNIFICANTLY LONGER THAN HUMALOGMIX * ADOCIA SA - ‍ALL TREATMENTS WERE WELL TOLERATED​ 
* ADOCIA SA - BOTH PRIMARY ENDPOINTS WERE MET IN STUDY Source text for Eikon: Further company coverage: